Because of prognostic markers, including estrogen receptor (ER), progesterone receptor (PR), CerbB-2, carcinoembryonic antigen, CA 15–3, CA 27.29, the risk classification of a BC patient’s outcome can be defined more accurately. The gene discussed is ESR1; the disease is breast cancer.